Safe administration of S-1 after 5-fluorouracil-induced cardiotoxicity in a patient with colorectal cancer
Authors:
- 22 May 2017
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Abstract
Cardiotoxicity is a rare but challenging complication of 5-fluorouracil (5-FU) therapy. Compared with 5-FU, after application of S-1 lower plasma levels of the cardiotoxic metabolite alpha-fluoro-beta-alanine have been reported. Evidence for safe administration of S-1 following 5-FU cardiotoxicity is limited to a case report in an Asian patient. Herein we report the first case of S-1 application after 5-FU cardiotoxicity in a Caucasian patient. A 67-year-old man with right-sided metastatic colorectal cancer and history of 5-FU cardiotoxicity had a progressive disease after 8-month therapy with irinotecan and bevacizumab. In consideration of known 5-FU cardiotoxicity, he was referred to our department for therapy counselling. We started a combination therapy with S-1, oxaliplatin and bevacizumab. The treatment was well tolerated without any cardiac problems. Our report confirms the safety of S-1 in cases of 5-FU cardiotoxicity also in a Caucasian patient.Keywords
This publication has 8 references indexed in Scilit:
- TAS-102, the first “cardio-gentle” fluoropyrimidine in the colorectal cancer landscape?BMC Cancer, 2016
- Experience with S-1 in older Caucasian patients with metastatic colorectal cancer (mCRC): Findings from an observational chart reviewActa Oncologica, 2016
- A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal CancerJournal of Cancer, 2015
- Alternative Treatment Options in Colorectal Cancer Patients With 5–Fluorouracil- or Capecitabine-Induced CardiotoxicityClinical Colorectal Cancer, 2013
- 5-fluorouracil induced cardiotoxicity: Review of the literatureCardiology Journal, 2012
- Comparison of the pharmacokinetics and pharmacodynamics of S‐1 between Caucasian and East Asian patientsCancer Science, 2010
- 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanineInternational Journal of Clinical Oncology, 2005
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000